Updated:
Iacocca Family Foundation
The Iacocca Family Foundation is an institutional investor and nonprofit foundation headquartered in Boston, United States. The firm's investment strategy...
Iacocca Family Foundation
The Iacocca Family Foundation is an institutional investor and nonprofit foundation headquartered in Boston, United States. The firm's investment strategy centers on funding medical research dedicated to curing Type 1 diabetes and alleviating the complications associated with the disease. Operating in the healthcare and life sciences sector, the foundation deploys its capital primarily through research grants rather than traditional equity investments. To date, the organization has funded over $40 million in scientific and medical research projects. Its approach targets initiatives that advance the understanding and treatment of Type 1 diabetes, focusing on impactful medical outcomes. The foundation does not seek traditional financial returns but rather invests in scientific progress within its specific disease focus. Through its grant-making activities, the Iacocca Family Foundation supports a portfolio of research projects aimed at medical breakthroughs. More information about its funded initiatives and operational focus can be found on its website at iacoccafoundation.org.
General information
Firm type
Institutional Investor
Location
Country
United States
City
Boston
Corporate office
Boston, United States
Sector focus
Frequently asked questions
What is the primary investment focus of the Iacocca Family Foundation?
The foundation primarily invests in and funds medical research focused on curing Type 1 diabetes and alleviating its complications.
How much has the Iacocca Family Foundation funded in research projects?
The foundation has funded over $40 million in research projects to date.
What type of investor is the Iacocca Family Foundation?
It is an institutional investor and nonprofit foundation headquartered in Boston, United States.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: